One Type of Diabetes Responds Better to a Weekly GLP-1 Drug Than to Insulin
A new study has found that a weekly injection of the GLP-1 drug dulaglutide is significantly more effective than daily insulin shots for treating a rare form of diabetes linked to the blood disorder transfusion-dependent beta-thalassaemia (TDT).